Trial Profile
Conventional Postoperative Radiotherapy (Standard Fractionation) Plus Iressa [gefitinib] or Hyperfractionated Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer: A Phase I Pilot Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2010
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gefitinib (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 21 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2008 New trial record.